These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14653830)

  • 1. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.
    Castiglione F; Rispo A; Di Girolamo E; Cozzolino A; Manguso F; Grassia R; Mazzacca G
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1107-12. PubMed ID: 14653830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
    Prantera C; Berto E; Scribano ML; Falasco G
    Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination ciprofloxacin and metronidazole for active Crohn's disease.
    Greenbloom SL; Steinhart AH; Greenberg GR
    Can J Gastroenterol; 1998; 12(1):53-6. PubMed ID: 9544412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.
    Lauritano EC; Gabrielli M; Scarpellini E; Ojetti V; Roccarina D; Villita A; Fiore E; Flore R; Santoliquido A; Tondi P; Gasbarrini G; Ghirlanda G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009; 13(2):111-6. PubMed ID: 19499846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response.
    Greco A; Caviglia GP; Brignolo P; Ribaldone DG; Reggiani S; Sguazzini C; Smedile A; Pellicano R; Resegotti A; Astegiano M; Bresso F
    Scand J Gastroenterol; 2015; 50(11):1376-81. PubMed ID: 25990116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test.
    Biancone L; Vernia P; Agostini D; Ferrieri A; Pallone F
    Curr Med Res Opin; 2000; 16(1):14-20. PubMed ID: 16422030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucose breath test: a diagnostic test for small bowel stricture(s) in Crohn's disease.
    Mishkin D; Boston FM; Blank D; Yalovsky M; Mishkin S
    Dig Dis Sci; 2002 Mar; 47(3):489-94. PubMed ID: 11911333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.
    Steinhart AH; Feagan BG; Wong CJ; Vandervoort M; Mikolainis S; Croitoru K; Seidman E; Leddin DJ; Bitton A; Drouin E; Cohen A; Greenberg GR
    Gastroenterology; 2002 Jul; 123(1):33-40. PubMed ID: 12105831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
    Thia KT; Mahadevan U; Feagan BG; Wong C; Cockeram A; Bitton A; Bernstein CN; Sandborn WJ
    Inflamm Bowel Dis; 2009 Jan; 15(1):17-24. PubMed ID: 18668682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum.
    Tahan S; Melli LC; Mello CS; Rodrigues MS; Bezerra Filho H; de Morais MB
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):316-8. PubMed ID: 23974062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease.
    Funayama Y; Sasaki I; Naito H; Fukushima K; Shibata C; Masuko T; Takahashi K; Ogawa H; Sato S; Ueno T; Noguchi M; Hiwatashi N; Matsuno S
    Dis Colon Rectum; 1999 Aug; 42(8):1072-7. PubMed ID: 10458133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth.
    Richard N; Desprez C; Wuestenberghs F; Leroi AM; Gourcerol G; Melchior C
    United European Gastroenterol J; 2021 Jul; 9(6):645-654. PubMed ID: 34241973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orocecal transit time and bacterial overgrowth in patients with Crohn's disease.
    Castiglione F; Del Vecchio Blanco G; Rispo A; Petrelli G; Amalfi G; Cozzolino A; Cuccaro I; Mazzacca G
    J Clin Gastroenterol; 2000 Jul; 31(1):63-6. PubMed ID: 10914780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.
    Nucera G; Gabrielli M; Lupascu A; Lauritano EC; Santoliquido A; Cremonini F; Cammarota G; Tondi P; Pola P; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1391-5. PubMed ID: 15932370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the glucose breath test in patients with inflammatory bowel disease.
    Lee JM; Lee KM; Chung YY; Lee YW; Kim DB; Sung HJ; Chung WC; Paik CN
    J Gastroenterol Hepatol; 2015 Jun; 30(6):990-4. PubMed ID: 25612007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
    Kasir R; Zakko S; Zakko P; Adler M; Lee A; Dhingra S; Guttermuth C
    Dig Dis Sci; 2016 Mar; 61(3):846-51. PubMed ID: 26362282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy.
    Tursi A; Brandimarte G; Giorgetti G; Nasi G
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):69-74. PubMed ID: 12544697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.
    Mow WS; Landers CJ; Steinhart AH; Feagan BG; Croitoru K; Seidman E; Greenberg GR; Targan SR
    Dig Dis Sci; 2004 Aug; 49(7-8):1280-6. PubMed ID: 15387358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antimicrobials in Crohn's disease.
    Kale-Pradhan PB; Zhao JJ; Palmer JR; Wilhelm SM
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):281-8. PubMed ID: 23445237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
    Angelberger S; Reinisch W; Dejaco C; Miehsler W; Waldhoer T; Wehkamp J; Lichtenberger C; Schaeffeler E; Vogelsang H; Schwab M; Teml A
    Am J Gastroenterol; 2008 May; 103(5):1197-202. PubMed ID: 18371140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.